These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 19424595
1. Ghrelin in patients with irritable bowel syndrome. El-Salhy M, Lillebø E, Reinemo A, Salmelid L. Int J Mol Med; 2009 Jun; 23(6):703-7. PubMed ID: 19424595 [Abstract] [Full Text] [Related]
2. The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals. Monem SMA, Elbadrawy EG, Shalaby SM, Hendawy DM, Hassan SM, Almonem NA. J Med Life; 2022 Dec; 15(12):1525-1531. PubMed ID: 36762339 [Abstract] [Full Text] [Related]
3. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. El-Salhy M, Gilja OH, Gundersen D, Hausken T. World J Gastrointest Endosc; 2014 May 16; 6(5):176-85. PubMed ID: 24891930 [Abstract] [Full Text] [Related]
4. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. El-Salhy M, Hatlebakk JG, Hausken T. World J Gastroenterol; 2015 Aug 28; 21(32):9577-87. PubMed ID: 26327765 [Abstract] [Full Text] [Related]
5. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. El-Salhy M, Vaali K, Dizdar V, Hausken T. Dig Dis Sci; 2010 Dec 28; 55(12):3508-13. PubMed ID: 20300845 [Abstract] [Full Text] [Related]
6. Relationship between irritable bowel syndrome and plasma and tissue ghrelin levels. Şahin-Eryılmaz G, Başak K, Çakır-Madenci Ö, Koç H, Tüzün S, Dolapçıoğlu C, Ahıshalı E, Dabak MR. Turk J Gastroenterol; 2018 Nov 28; 29(6):631-635. PubMed ID: 30289393 [Abstract] [Full Text] [Related]
7. Stomach antral endocrine cells in patients with irritable bowel syndrome. El-Salhy M, Gilja OH, Hatlebakk JG, Hausken T. Int J Mol Med; 2014 Oct 28; 34(4):967-74. PubMed ID: 25110039 [Abstract] [Full Text] [Related]
8. Covariation of plasma ghrelin and motilin in irritable bowel syndrome. Sjölund K, Ekman R, Wierup N. Peptides; 2010 Jun 28; 31(6):1109-12. PubMed ID: 20338210 [Abstract] [Full Text] [Related]
9. [Small intestine motility and gastrointestinal hormone levels in irritable bowel syndrome]. Zhao JH, Dong L, Hao XQ. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct 28; 27(10):1492-5. PubMed ID: 17959521 [Abstract] [Full Text] [Related]
10. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. World J Gastroenterol; 2019 Jan 14; 25(2):269-281. PubMed ID: 30670915 [Abstract] [Full Text] [Related]
11. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. El-Salhy M, Gundersen D, Hatlebakk JG, Gilja OH, Hausken T. Regul Pept; 2014 Jan 10; 188():60-5. PubMed ID: 24316398 [Abstract] [Full Text] [Related]
12. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. El-Salhy M, Mazzawi T, Gundersen D, Hausken T. Mol Med Rep; 2012 Dec 10; 6(6):1223-5. PubMed ID: 22992886 [Abstract] [Full Text] [Related]
13. The obestatin/ghrelin ratio and ghrelin genetics in adult celiac patients before and after a gluten-free diet, in irritable bowel syndrome patients and healthy individuals. Russo F, Chimienti G, Linsalata M, Clemente C, Orlando A, Riezzo G. Eur J Gastroenterol Hepatol; 2017 Feb 10; 29(2):160-168. PubMed ID: 27750262 [Abstract] [Full Text] [Related]
14. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease. El-Salhy M, Wendelbo I, Gundersen D. Mol Med Rep; 2013 Aug 10; 8(2):451-5. PubMed ID: 23778763 [Abstract] [Full Text] [Related]
15. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. El-Salhy M, Wendelbo IH, Gundersen D. Mol Med Rep; 2013 Apr 10; 7(4):1241-4. PubMed ID: 23426642 [Abstract] [Full Text] [Related]
16. Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome. Furgała A, Ciesielczyk K, Przybylska-Feluś M, Jabłoński K, Gil K, Zwolińska-Wcisło M. Sci Rep; 2023 Jun 09; 13(1):9420. PubMed ID: 37296188 [Abstract] [Full Text] [Related]
17. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease. Wendelbo I, Mazzawi T, El-Salhy M. Mol Med Rep; 2014 Jan 09; 9(1):180-4. PubMed ID: 24213511 [Abstract] [Full Text] [Related]
18. The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome. Koçak E, Akbal E, Köklü S, Ergül B, Can M. Intern Med; 2016 Jan 09; 55(9):1043-8. PubMed ID: 27150852 [Abstract] [Full Text] [Related]
19. [Melatonin secretion and metabolism in patients with irritable bowel syndrome]. Stepień A, Moskwa-Fortuna A, Wisniewska-Jarosińska M, Harasiuk A, Chojnacki J. Pol Merkur Lekarski; 2009 May 09; 26(155):440-3. PubMed ID: 19606692 [Abstract] [Full Text] [Related]
20. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome. El-Salhy M, Gilja OH, Hausken T. Mol Med Rep; 2014 Oct 09; 10(4):1753-7. PubMed ID: 25109259 [Abstract] [Full Text] [Related] Page: [Next] [New Search]